
Program
2022 GMFH Summit
All times are in local time – Eastern Standard Time (EST), UTC -5
Friday, March 11
1 pm – Satellite symposium: Gut Health and the Microbiome – A Workshop for Registered Dietitians
By invitation only. This program is made possible by support from Danone North America.
3 pm – Registration (until 6 pm)
Saturday, March 12
7 am – Breakfast and Registration
8:30 am – Welcome
Gail A. Hecht, MD, MS, Loyola University Medical Center (U.S.) – virtual presentation
8:45 am – Keynote Lecture
The promise of the gut microbiome as part of individualized treatment strategies
Purna Kashyap, MBBS, Mayo Clinic (U.S.)
9:15 am – PLENARY SESSION 1: Impact of Diet on the Human Gut Microbiome
Moderator: Gary D. Wu, MD, University of Pennsylvania School of Medicine (U.S.)
- Effect of immigration on the gut microbiome
Dan Knights, PhD, University of Minnesota (U.S.) – virtual presentation - Effect of cooking on the microbiome
Rachel Carmody, PhD, Harvard University (U.S.) - Metabolome patterns in response to diet – impact of microbiome
Gary D. Wu, MD, University of Pennsylvania School of Medicine (U.S.)
10:45 am – Morning Break
11:15 am – PLENARY SESSION 2: Gut Microbiota in Precision Medicine
Moderator: Giovanni Barbara, MD, University of Bologna (Italy)
- Precision nutrition and the human gut microbiome
Nicola Segata, PhD, University of Trento (Italy) – virtual presentation - Brain-gut axis in functional gastrointestinal disorders
Emeran Mayer, MD, UCLA (U.S.)– virtual presentation - Circadian rhythm and gut microbiome signatures in type 2 diabetes
Dirk Haller, PhD, Technical University of Munich (Germany)
12:45 pm – Lunch
1:15 pm – Product Theater: The Power of the Microbiome – Can it be unlocked to break the cycle of recurrent Clostridioides difficile infection?
Paul Feuerstadt, MD, Yale-New Haven Hospital and PACT-Gastrocenter
Presented by Ferring Pharmaceuticals, Inc.
2 pm – Breakout Sessions (two concurrent sessions – in-person only)
- Workshop 1: Defining a “healthy” microbiome
Eugene B. Chang, MD, University of Chicago (U.S.)
R. Balfour Sartor, MD, University of North Carolina-Chapel Hill (U.S.) - Workshop 2: Circadian control of microbiota functionality
Dirk Haller, PhD, Technical University of Munich (Germany)
Vanessa Leone, PhD, University of Wisconsin-Madison (U.S.)
3:15 pm – Afternoon Break
3:45 pm – Breakout Sessions (two concurrent sessions – in-person only)
- Workshop 3: Designing microbiome trials – unique considerations
Brendan J. Kelly, MD, University of Pennsylvania (U.S.)
Geoffrey A. Preidis, MD, PhD, Baylor College of Medicine and Texas Children’s Hospital (U.S.) - Workshop 4: Modulating microbial pathways as a therapeutic strategy
Gary D. Wu, MD, University of Pennsylvania (U.S.)
Harry Sokol, MD, PhD, Sorbonne Université, APHP (France)– virtual presentation
5 pm – Networking Reception
7 pm – End of Day 1
Sunday, March 13
(Eastern Daylight Time starting 2 am on March 13)
7 am – Breakfast and Registration
8:30 am – PLENARY SESSION 3: Update on Microbiota-based Therapies
Moderator: Colleen R. Kelly, MD, Alpert Medical School of Brown University (U.S)
- Status of commercial stool-based therapies
Sahil Khanna, MD, Mayo Clinic (U.S.) - Mining the gut microbiota and identifying effector microbes to combat pathogen infection
Kenya Honda, MD, PhD, Keio University School of Medicine (Japan) – virtual presentation - Microbiota as a modulator of cancer therapy
Jennifer A. Wargo, MD, MMSc, MD Anderson Cancer Center (U.S.) – virtual presentation
10 am – Morning Break
10:30 am – PLENARY SESSION 4: Probiotics – Outlook for the Future
Moderator: Purna Kashyap, MBBS, Mayo Clinic (U.S.)
- Rational selection of microbes as probiotics
Eric Alm, PhD, MIT (U.S.) - Genetically engineered bacteria and synthetic bacteria as probiotics
Philippe Langella, PhD, INRA (France) - Microbiota-derived small molecules as probiotics
Sloan Devlin, PhD, Harvard Medical School (U.S.)
12 pm – Closing Lecture
COVID-19, the GI Tract, and the Microbiome: What Do We Know Today?
Siew C. Ng, MBBS, PhD, Chinese University of Hong Kong – virtual presentation.
12:30 pm – Closing Remarks
Harry Sokol, MD, PhD, Sorbonne Université, APHP (France) – virtual presentation
12:35 pm – End of Program
CME information
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Gastroenterological Association (AGA) Institute and the European Society of Neurogastroenterology & Motility (ESNM).
The AGA Institute is accredited by the ACCME to provide continuing medical education for physicians. The AGA Institute designates this live activity for a maximum of 9.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Harry Sokol, MD, PhD (co-chair)
Giovanni Barbara, MD
Joël Doré, PhD
Francisco Guarner, MD, PhD
Dirk Haller, PhD
Purna Kashyap, MBBS
Colleen R. Kelly, MD
Emeran A. Mayer, MD
D. Brent Polk, MD
R. Balfour Sartor, MD
Robert F. Schwabe, MD
Hania Szajewska, MD
Michael Trauner, MD
Gary D. Wu, MD